University of Arizona

Enrollment strategies in the PMI Cohort Study will bolster diversity in clinical research industry-wide

Monday, July 25, 2016

The Precision Medicine Initiative (PMI) Cohort Program is an ambitious observational study backed by the National Institutes of Health (NIH) that seeks to enroll at least one million Americans by 2020. Because of its massive scale, the Cohort Program is often compared to the 1948 Framingham Heart Study. Yet a crucial differentiator is that the Cohort Program aims to recruit participants with diverse backgrounds and ethnicities to better understand the root cause of disease for all Americans.

[Read More]

NIH awards $55M to build million-person precision medicine study

Thursday, July 7, 2016

The NIH has announced $55 million in awards in fiscal year 2016 to build the foundational partnerships and infrastructure needed to launch the Cohort Program of President Obama’s Precision Medicine Initiative (PMI). The PMI Cohort Program is a landmark longitudinal research effort that aims to engage 1 million or more U.S. participants to improve our ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.

[Read More]

Johnson & Johnson Innovation inks 17 collaborations

Friday, June 12, 2015

Johnson & Johnson Innovation has announced 17 new collaborations with research institutions and healthcare companies, bringing the total number of collaborations formed since the 2013 launch of Johnson & Johnson Innovation to more than 200. Johnson & Johnson Innovation seeks to identify and advance scientific innovation across the Johnson & Johnson segments of Pharmaceutical, Medical Devices and Consumer businesses.

[Read More]

Andrew S. Kraft named director of University of Arizona Cancer Center

Monday, June 9, 2014

Dr. Andrew S. Kraft, a prostate cancer physician-scientist and cancer center administrator, has been named the Sydney E. Salmon endowed chair and director of the University of Arizona Cancer Center and associate vice president for oncology programs for the UA Health Sciences Center. In addition, Kraft joins the University as a tenured professor of medicine in the department of Medicine’s Division of Hematology/Oncology and senior associate dean for translational research in the College of Medicine.

[Read More]

Michael S. Gordon named medical director for cancer center trials at Scottsdale Healthcare

Friday, April 25, 2014

Michael S. Gordon, M.D., has been named the new medical director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Gordon will oversee the center’s phase I clinical trials program. Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership with Translational Genomics Research Institute, is a clinical research site for phase I studies of new cancer drugs.

[Read More]